Cargando…
ESR, CRP, and failure of Arterio-Venous Fistula (AVF)
Background: The survival of arteriovenous fistula (AVF) remains an important problem for hemodialysis patients, accounting for 20% of all hospitalizations related to AV access problems in western countries. We designed an observational prospective cohort study on 265 AVFs and evaluated their results...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iran University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840846/ https://www.ncbi.nlm.nih.gov/pubmed/35321365 http://dx.doi.org/10.47176/mjiri.35.125 |
_version_ | 1784650715639054336 |
---|---|
author | Khavanin Zadeh, Morteza Omrani, Zahra Cheraghali, Roozbeh Hashemaghaee, Mehdi |
author_facet | Khavanin Zadeh, Morteza Omrani, Zahra Cheraghali, Roozbeh Hashemaghaee, Mehdi |
author_sort | Khavanin Zadeh, Morteza |
collection | PubMed |
description | Background: The survival of arteriovenous fistula (AVF) remains an important problem for hemodialysis patients, accounting for 20% of all hospitalizations related to AV access problems in western countries. We designed an observational prospective cohort study on 265 AVFs and evaluated their results after 4 months of fistula creation and its relation to laboratory tests as ESR and CRP levels. Methods: Wrist or antecubital AVFs were created for patients with End-Stage renal disease. All laboratory tests (ESR and CRP) were checked quantitatively. The patients were followed-upfor at least 4 months and failure or maturation of AVFs were recorded in a checklist. Results: 177 (66.8%) males and 88 (33.2%) females were included. The surgeon created 161(60.8%) wrist and 98 (37%) antecubital AVFs. The mean age of patients was 53.18±17.1, ranged from 8 to 91 years old. CRP and total protein had significant differences between the two groups of failure and mature accesses (0.029 and 0.045 respectively). Conclusion: High CRP level is recognized as a reliable predictor for the survival of AVF. |
format | Online Article Text |
id | pubmed-8840846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Iran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-88408462022-03-22 ESR, CRP, and failure of Arterio-Venous Fistula (AVF) Khavanin Zadeh, Morteza Omrani, Zahra Cheraghali, Roozbeh Hashemaghaee, Mehdi Med J Islam Repub Iran Original Article Background: The survival of arteriovenous fistula (AVF) remains an important problem for hemodialysis patients, accounting for 20% of all hospitalizations related to AV access problems in western countries. We designed an observational prospective cohort study on 265 AVFs and evaluated their results after 4 months of fistula creation and its relation to laboratory tests as ESR and CRP levels. Methods: Wrist or antecubital AVFs were created for patients with End-Stage renal disease. All laboratory tests (ESR and CRP) were checked quantitatively. The patients were followed-upfor at least 4 months and failure or maturation of AVFs were recorded in a checklist. Results: 177 (66.8%) males and 88 (33.2%) females were included. The surgeon created 161(60.8%) wrist and 98 (37%) antecubital AVFs. The mean age of patients was 53.18±17.1, ranged from 8 to 91 years old. CRP and total protein had significant differences between the two groups of failure and mature accesses (0.029 and 0.045 respectively). Conclusion: High CRP level is recognized as a reliable predictor for the survival of AVF. Iran University of Medical Sciences 2021-09-28 /pmc/articles/PMC8840846/ /pubmed/35321365 http://dx.doi.org/10.47176/mjiri.35.125 Text en © 2021 Iran University of Medical Sciences https://creativecommons.org/licenses/by-nc/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial-ShareAlike 1.0 License (CC BY-NC-SA 1.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly. |
spellingShingle | Original Article Khavanin Zadeh, Morteza Omrani, Zahra Cheraghali, Roozbeh Hashemaghaee, Mehdi ESR, CRP, and failure of Arterio-Venous Fistula (AVF) |
title | ESR, CRP, and failure of Arterio-Venous Fistula (AVF) |
title_full | ESR, CRP, and failure of Arterio-Venous Fistula (AVF) |
title_fullStr | ESR, CRP, and failure of Arterio-Venous Fistula (AVF) |
title_full_unstemmed | ESR, CRP, and failure of Arterio-Venous Fistula (AVF) |
title_short | ESR, CRP, and failure of Arterio-Venous Fistula (AVF) |
title_sort | esr, crp, and failure of arterio-venous fistula (avf) |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840846/ https://www.ncbi.nlm.nih.gov/pubmed/35321365 http://dx.doi.org/10.47176/mjiri.35.125 |
work_keys_str_mv | AT khavaninzadehmorteza esrcrpandfailureofarteriovenousfistulaavf AT omranizahra esrcrpandfailureofarteriovenousfistulaavf AT cheraghaliroozbeh esrcrpandfailureofarteriovenousfistulaavf AT hashemaghaeemehdi esrcrpandfailureofarteriovenousfistulaavf |